Healthcare News

$27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to holders of CombiMatrix Series F Warrants (Nasdaq: CBMXW) IRVINE,...

TORONTO, ONTARIO--(Marketwired - July 31, 2017) - Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...

PTI-801 Moving to 14 Day Proof of Concept Study in CF Subjects on Orkambi®PTI-428 Continues to Enroll 28 Day Proof of Concept Study in CF Subjects on Orkambi®PTI-808 Investigational New Drug...

Reports multiple recent developments and milestones Plans to report top-line results from the second monotherapy dosing cohort of the ACHIEVE global Phase 2 clinical trial of SB 9200 in chronic HBV...

CAMBRIDGE, Mass., July 31, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...

RAMSEY, N.J. and BOCA RATON, Fla., July 31, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) is a vertically integrated biopharmaceutical and specialty immunoglobulin  company  that...

Uppsala, 2017-07-31 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (publ) (”Oasmia” eller ”Bolaget”) har som tidigare meddelats genomfört en företrädesemission. Cirka hälften av aktierna i...

Uppsala, Sweden, 2017-07-31 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) has, as has been previously announced, carried out a rights issue....

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASEREGULATED INFORMATION ...

CHICAGO, July 31, 2017 (GLOBE NEWSWIRE) -- Catholic Medical Center (CMC) in Manchester, NH has expanded its portfolio of Allscripts (NASDAQ:MDRX) solutions to offer a fully–integrated,...